[go: up one dir, main page]

BRPI1006915B8 - composição compreendendo extrato lipofílico de zingiber officinale e extrato de cynara scolymus, e seu uso - Google Patents

composição compreendendo extrato lipofílico de zingiber officinale e extrato de cynara scolymus, e seu uso

Info

Publication number
BRPI1006915B8
BRPI1006915B8 BRPI1006915A BRPI1006915A BRPI1006915B8 BR PI1006915 B8 BRPI1006915 B8 BR PI1006915B8 BR PI1006915 A BRPI1006915 A BR PI1006915A BR PI1006915 A BRPI1006915 A BR PI1006915A BR PI1006915 B8 BRPI1006915 B8 BR PI1006915B8
Authority
BR
Brazil
Prior art keywords
extract
cynara scolymus
composition
zingiber officinale
lipophilic
Prior art date
Application number
BRPI1006915A
Other languages
English (en)
Inventor
Bombardelli Ezio
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT000051A external-priority patent/ITMI20090051A1/it
Priority claimed from ITMI2009A001358A external-priority patent/IT1395119B1/it
Application filed by Indena Spa filed Critical Indena Spa
Publication of BRPI1006915A2 publication Critical patent/BRPI1006915A2/pt
Publication of BRPI1006915B1 publication Critical patent/BRPI1006915B1/pt
Publication of BRPI1006915B8 publication Critical patent/BRPI1006915B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

composições compreendendo um extrato lipofílico de zingiber officinale e um extrato de cynara scolymus que são úteis para a prevenção e tratamento de refluxo esofágico e da síndrome do cólon irritável. a presente invenção refere-se a composições consistindo em uma combinação de extrato de zingiber offcinales e um extrato de cynara scolymus, que são úteis para a aprevenção e tratamento do refluxo esofágico e da síndrome do cólon irritável, para a redução da sonolência pós-prandial e tendo atividades procinéticas e antidispépticas.
BRPI1006915A 2009-01-20 2010-01-15 composição compreendendo extrato lipofílico de zingiber officinale e extrato de cynara scolymus, e seu uso BRPI1006915B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IT000051A ITMI20090051A1 (it) 2009-01-20 2009-01-20 Composizioni a base di estratto lipofilo di zingiber officinale e di estratto di cynara scolymus per la prevenzione e il trattamento del riflusso esofageo e della sindrome del colon irritabile
ITMI2009A000051 2009-01-20
ITMI2009A001358 2009-07-29
ITMI2009A001358A IT1395119B1 (it) 2009-07-29 2009-07-29 Composizioni a base di estratto lipofilo di zingiber officinale e di estratto di cynara scolymus per la prevenzione e il trattamento del riflusso esofageo e della sindrome del colon irritabile
PCT/EP2010/000205 WO2010083968A1 (en) 2009-01-20 2010-01-15 Compositions comprising a lipophilic extract of zingiber officinale and an extract of cynara scolymus, which are useful for the prevention and treatment of oesophageal reflux and irritable bowel syndrome

Publications (3)

Publication Number Publication Date
BRPI1006915A2 BRPI1006915A2 (pt) 2016-02-16
BRPI1006915B1 BRPI1006915B1 (pt) 2021-01-26
BRPI1006915B8 true BRPI1006915B8 (pt) 2021-05-25

Family

ID=41820719

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1006915A BRPI1006915B8 (pt) 2009-01-20 2010-01-15 composição compreendendo extrato lipofílico de zingiber officinale e extrato de cynara scolymus, e seu uso

Country Status (20)

Country Link
US (1) US10220065B2 (pt)
EP (1) EP2379092B1 (pt)
JP (1) JP5769634B2 (pt)
KR (1) KR101762388B1 (pt)
CN (1) CN102281886A (pt)
AU (1) AU2010206327B2 (pt)
BR (1) BRPI1006915B8 (pt)
CA (1) CA2750030C (pt)
CL (1) CL2011001752A1 (pt)
DK (1) DK2379092T3 (pt)
ES (1) ES2451346T3 (pt)
HR (1) HRP20140197T1 (pt)
IL (1) IL214160A (pt)
MX (1) MX2011007686A (pt)
PL (1) PL2379092T3 (pt)
PT (1) PT2379092E (pt)
RU (1) RU2521250C2 (pt)
SG (1) SG173053A1 (pt)
SI (1) SI2379092T1 (pt)
WO (1) WO2010083968A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101074839B1 (ko) * 2010-11-25 2011-10-19 주식회사 녹십자 금은화 추출물을 포함하는 역류성 식도염 치료 또는 예방용 약학조성물
KR101420347B1 (ko) * 2011-01-31 2014-07-16 성균관대학교산학협력단 클로로겐산을 포함하는 위식도 역류 질환의 예방 또는 치료용 조성물
ITMI20111670A1 (it) * 2011-09-16 2013-03-17 Indena Spa Estratti di cynara scolimus per il trattamento di dislipidemie
ITMI20121570A1 (it) * 2012-09-20 2014-03-21 Indena Spa Nuovi estratti di cynara scolimus, coffea spp. e olea europaea per il trattamento della sindrome metabolica
AU2014202932A1 (en) * 2013-05-30 2014-12-18 Visa International Service Association Dynamic checkout button apparatuses, methods and systems
KR101549746B1 (ko) * 2013-08-22 2015-09-04 충북대학교 산학협력단 생강의 용매분획을 유효성분으로 포함하는 기능성 위장장애 및 위장관 운동장애의 예방 및 치료용 약학적 조성물
US20160189213A1 (en) * 2014-12-31 2016-06-30 Green Dot Corporation Systems and Methods for Targeting Advertising based on Future Purchases
KR102157795B1 (ko) 2018-12-06 2020-09-18 (주)녹십자웰빙 금은화 물 추출물을 포함하는 헬리코박터 파일로리 감염증 예방 또는 치료용 약학 조성물
IT202000003092A1 (it) * 2020-02-17 2021-08-17 Neilos S R L Composizione per la protezione della mucosa gastro-intestinale e per la prevenzione e il trattamento di patologie ad essa associate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO990397A0 (en) * 1997-10-22 1997-11-13 R.P. Scherer Holdings Pty Ltd Clear solutions of herbal extracts
DE19859499C2 (de) 1998-12-22 2002-10-24 Schwabe Willmar Gmbh & Co Stabile Ingwerextraktzubereitung
US20010046523A1 (en) 2000-02-25 2001-11-29 Thomas Newmark Ginger-based herbal composition for promoting health and methods of using same
TWI290469B (en) * 2000-07-12 2007-12-01 Medical & Pharm Ind Tech & Dev Method for manufacturing product with component capable of efficiently preventing inflammation and platelets agglutination form ginger and medical composition with the efficient component
DE10138929A1 (de) * 2001-08-08 2003-02-27 Lichtwer Pharma Ag Artischockenblätterextrakte
ITMI20051347A1 (it) * 2005-07-14 2007-01-15 Indena Spa Estratti di cynara scolimus loro uso e formulazioni che li contengono
US20080113042A1 (en) * 2006-09-05 2008-05-15 Chu Kee Hung Pharmaceutical composition and method for cancer treatment based on combinational use of conventional anticancer agents and geranium oil or compounds thereof
WO2008070783A2 (en) * 2006-12-07 2008-06-12 Herbalscience Singapore Pte. Ltd. Compositions and methods comprising zingiber species
WO2008074080A1 (en) 2006-12-20 2008-06-26 David Lubowski Composition and method for treatment of ibs
EP1967199A1 (en) * 2007-03-07 2008-09-10 Indena S.P.A. Cynara scolymus extracts and compositions containing them

Also Published As

Publication number Publication date
US10220065B2 (en) 2019-03-05
AU2010206327B2 (en) 2015-06-04
CA2750030C (en) 2017-11-07
ES2451346T3 (es) 2014-03-26
BRPI1006915B1 (pt) 2021-01-26
EP2379092A1 (en) 2011-10-26
SG173053A1 (en) 2011-08-29
RU2011129991A (ru) 2013-02-27
JP5769634B2 (ja) 2015-08-26
PT2379092E (pt) 2014-03-13
CA2750030A1 (en) 2010-07-29
SI2379092T1 (sl) 2014-03-31
PL2379092T3 (pl) 2014-05-30
IL214160A0 (en) 2011-08-31
EP2379092B1 (en) 2013-12-25
WO2010083968A1 (en) 2010-07-29
US20120015060A1 (en) 2012-01-19
MX2011007686A (es) 2011-08-12
IL214160A (en) 2016-03-31
JP2012515716A (ja) 2012-07-12
BRPI1006915A2 (pt) 2016-02-16
CN102281886A (zh) 2011-12-14
KR101762388B1 (ko) 2017-07-28
HRP20140197T1 (hr) 2014-04-11
AU2010206327A1 (en) 2011-08-11
DK2379092T3 (da) 2014-01-27
RU2521250C2 (ru) 2014-06-27
KR20110107340A (ko) 2011-09-30
CL2011001752A1 (es) 2012-02-03

Similar Documents

Publication Publication Date Title
BRPI1006915B8 (pt) composição compreendendo extrato lipofílico de zingiber officinale e extrato de cynara scolymus, e seu uso
CL2012002606A1 (es) Composicion farmaceutica que comprende (-)-carvona, (+)-carvona, trans-geraniol y al menos un componente elegido de aceites esenciales para uso en el tratamiento y prevencion de enfermedades virales.
MX384206B (es) Formulaciones de inhibidores de dpp iv
MX338712B (es) Composicion farmaceutica que comprende linagliptina y opcionalmente un inhibidor de sglt2, y usos de la misma.
CL2012003643A1 (es) Compuesto analogo del glucagon; composicion que comprende dicho compuesto; uso del compuesto para tratar y/o prevencion de obesidad, dislipidemia o hipertension.
BRPI0911019A2 (pt) "composição farmacêutica, especialidade farmacêutica, progesterona micronizada em óleo de cártamo de tipo ii e uso da progesterona micronizada em cártamo óleo de tipo ii"
MX339402B (es) Composiciones y metodos que comprenden variantes de serina proteasa.
UY32728A (es) Composición farmacéutica y procedimiento de tratamiento para la anticoncepción de emergencia
UA118177C2 (uk) Композиція для лікування гіперліпідемії, яка містить похідну оксинтомодуліну
BRPI0912717A2 (pt) Composição farmacêutica, e, uso de 5-azacitidina
UY32389A (es) Composición farmacéutica sólida que comprende amlodipina y losartan con estabilidad mejorada
CL2014000801A1 (es) Variante de factor 21 de crecimiento de fibroblasto humano (fgf21); composicion farmaceutica que lo comprende; y su uso para tratar diabetes tipo 2, obesidad, dislipidemia, sindrome metabolico o cualquier combinacion de los mismos.
BRPI0908021A2 (pt) Composto, composição farmacêutica, e, usos do composto ou da composição farmacêutica
AR070497A1 (es) Composicion detergente que comprende lipasa
BRPI0815841A2 (pt) Métodos e composições para melhoramento de traços preferidos.
MX2011009690A (es) Métodos y composiciones para trastornos relacionados con la proliferación celurar.
BRPI0917017B8 (pt) inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos
AR065721A1 (es) Derivados de piridazinona utiles como inhibidores de glucano sintasa. composiciones farmaceuticas.
CL2007002971A1 (es) Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.
MX379016B (es) Composiciones y metodos para tratar enfermedad de gaucher.
BRPI1014583A2 (pt) sulfonamidas heterocíclicos, composições farmacêuticas e usos do mesmo.
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
CL2009001298A1 (es) Compuestos derivados de n-ciclohexil-2-fenoxinicotinamida; composición farmcéutica que los comprende; combinación farmacéutica que los comprende; y su uso para tratar una enfermedad mediada por la pde4.
CL2007002970A1 (es) Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.
BRPI1006849B8 (pt) composição compreendendo extratos lipofílicos de zingiber officinale e echinacea angustifolia e seu uso na preparação de um medicamento para prevenção e tratamento de refluxo esofágico

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2475 DE 12/06/2018 POR TER SIDO INDEVIDA.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/01/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/01/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF